Diminished Susceptibility to Daptomycin Accompanied by Clinical Failure in a Patient With Methicillin-Resistant Staphylococcus aureus Bacteremia

2006 ◽  
Vol 27 (3) ◽  
pp. 315-317 ◽  
Author(s):  
David Hirschwerk ◽  
Christine C. Ginocchio ◽  
Maureen Bythrow ◽  
Susan Condon

We cared for a patient with methicillin-resistant Staphylococcus aureus bacteremia who experienced clinical failure with daptomycin. The failure was accompanied by progressive elevation of the daptomycin minimum inhibitory concentration during treatment. DNA fingerprinting confirmed that the minimum inhibitory concentration elevation occurred within the same strain of methicillin-resistant Staphylococcus aureus. This observation provides important new information to clinicians who adopt this promising drug for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus.

2012 ◽  
Vol 33 (12) ◽  
pp. 1246-1249 ◽  
Author(s):  
Christian J. Woods ◽  
Anindita Chowdhury ◽  
Vinay M. Patel ◽  
Andrew F. Shorr

We retrospectively evaluated 99 intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia to determine whether having a vancomycin minimum inhibitory concentration (MIC) of 2 mg/L affected mortality. This MIC was found in 5.1% of patients and was associated with the probability of death (adjusted odds ratio, 13.9 [95% confidence interval, 1.1–171.2]) independent of other factors.


Sign in / Sign up

Export Citation Format

Share Document